NCT04252144

Brief Summary

The aim of the study is to assess food diversity and dietary patterns in Russian GERD patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 31, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

February 3, 2022

Status Verified

February 1, 2022

Enrollment Period

3.7 years

First QC Date

January 31, 2020

Last Update Submit

February 2, 2022

Conditions

Keywords

food diversitydietary patternhealthy eating patternoesophagitisGERD

Outcome Measures

Primary Outcomes (8)

  • grains consumption diversity

    Mean number of different types of grains consumed in form of different foods or food products a month during 12-months period

    a month

  • meat consumption diversity

    Mean number of different types of meat consumed in form of different foods or food products a month during 12-months period

    a month

  • poultry consumption diversity

    Mean number of different types of poultry consumed in form of different foods or food products a month during 12-months period

    a month

  • fish consumption diversity

    Mean number of different types of fish consumed in form of different foods or food products a month during 12-months period

    a month

  • flour consumption diversity

    Mean number of different types of flours consumed in form of different foods or food products a month during 12-months period

    a month

  • vegetables consumption diversity

    Mean number of different types of vegetables consumed as is or in the form of different foods or food products

    a month

  • Fruits consumption diversity

    Mean number of different types of fruits consumed as is or in the form of different foods or food products

    a month

  • Fats consumption diversity

    Mean number of different types of fats consumed in the form of different foods or food products a month by 12 month period

    a month

Secondary Outcomes (1)

  • GERD-associated dietary pattern

    a year

Study Arms (2)

GERD

EXPERIMENTAL

Patients with verified gastroesophageal reflux disease

Procedure: Dietary assessment

Contol

OTHER

Mostly healthy subjects who have no symptoms and other manifestations of gastroesophageal reflux disease by complex examination

Procedure: Dietary assessment

Interventions

Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.

Also known as: Food frequency questionnaire
ContolGERD

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • willingness to participate (signed the informed consent form);
  • willingness to follow all the required procedures;

You may not qualify if:

  • Pregnant or breast-feeding females;
  • Neoplasms, current or by the medical history (except local skin cancer successfully treated);
  • History of chest or abdominal surgery, except appendectomy and cholecistectomy (in case when no consequences of these operations like adhesive disease of the abdominal cavity are present);
  • Co-morbid conditions which can influence or mask the symptoms of GERD (including, but not limited to: ischaemic heart disease, severe pulmonary disease, severe depression or anxiety, etc);
  • the use of concomitant medications that may influence on the symptoms or other manifestations of gastroesophageal reflux disease: NSAIDs, corticosteroids (except topic ones for no longer than 2 weeks), any medications directly influencing mood and function of central nervous system (antidepressants, anxiolytics, anti-anxiety agents, anticonvulsant etc) at the moment of enrolment and during a 2 half-life period of the certain drug;
  • the use of medications that influence gastric secretion at the time of enrolment and during 2 week before it;
  • any condition of the patient which makes the participation of the patient in the study unreasonable or put him at risk of the condition's exacerbation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastroenterology and Hepatology, FRC Nutrition and Biotechnology

Moscow, 115446, Russia

RECRUITING

MeSH Terms

Conditions

Esophagitis, PepticGastroesophageal RefluxHeartburnNon-Erosive Reflux DiseaseEsophagitis

Interventions

Nutrition Assessment

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesGastroenteritisPeptic UlcerDuodenal DiseasesIntestinal DiseasesStomach DiseasesEsophageal Motility DisordersDeglutition DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Vasily Isakov, MD, PhD, Professor, AGAF

    FRC nutrition and biotechnology

    STUDY CHAIR
  • Sergey Morozov, MD, PhD

    FRC Nutrition and Biotechnology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sergey Morozov, MD, PhD

CONTACT

Vasily Kropochev, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: Dietary assessment with the use of computer-based food frequency questionnaire will be performed to patients with established diagnosis of gastroesophageal reflux disease in comparison to the representatives of a control group (without the disease).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Professor, AGAF

Study Record Dates

First Submitted

January 31, 2020

First Posted

February 5, 2020

Study Start

January 30, 2020

Primary Completion

September 30, 2023

Study Completion

December 31, 2023

Last Updated

February 3, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

Study data may be shared by request after study completion, except subjects' personal (identification) information

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After the study completion, available for 2 years
Access Criteria
By request
More information

Locations